OBI Pharma (ROCO:4174) Institutional Ownership: 3.19% (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4174 OBI Pharma Inc ROCO:4174
28 GF Score
Price NT$25.95
! 8 Warning Signs
View Full Analysis

What is OBI Pharma Institutional Ownership?

OBI Pharma ROCO:4174 -1.52% 28 Institutional Ownership is 3.19% as of Aug. 18, 2026. GuruFocus rates ROCO:4174 with a GF Score™ of 28/100. The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OBI Pharma's institutional ownership is 3.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OBI Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OBI Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

OBI Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for OBI Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OBI Pharma Institutional Ownership Chart

OBI Pharma Historical Data

The historical data trend for OBI Pharma can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 2.92 2.94 3.05 5.98 3.06 3.11 3.13 3.14 3.18 3.19
ROCO:4174
28GF Score
OBI Pharma Inc ROCO:4174
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OBI Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.19% mean?
OBI Pharma (ROCO:4174) has a Institutional Ownership of 3.19% as of Aug. 18, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OBI Pharma and its competitors.
Is OBI Pharma's Institutional Ownership too high?
OBI Pharma's current Institutional Ownership is 3.19%. Overall, OBI Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does OBI Pharma's Institutional Ownership compare to VRTX and REGN?
OBI Pharma's Institutional Ownership of 3.19% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OBI Pharma and its competitors. OBI Pharma's current Institutional Ownership is 3.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OBI Pharma stock overvalued right now?
OBI Pharma (ROCO:4174) has a current Institutional Ownership of 3.19%. The current Institutional Ownership is 3.19%. OBI Pharma's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For OBI Pharma (ROCO:4174), the current Institutional Ownership is 3.19% as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OBI Pharma Business Description

Address Zhongxiao East Road, 6th Floor, No. 508, Section 7, Nangang District, Taipei, TWN, 115
OBI Pharma Inc is engaged in the research and development of novel therapeutic agents and biologics for patients with unmet medical needs. The company has three reportable segments: the anti-cancer new drug segment, the botulinum toxin new drug segment, and the CDMO segment. Geographically, it generates the majority of its revenue from Taiwan.
28GF Score

Get the complete analysis for ROCO:4174

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.95
Price